AFLAC INC. 2004 Annual Report (10-K) Summary
Business Context and Reporting Period
This report covers the fiscal year ended December 31, 2004. AFLAC Incorporated is a holding company primarily engaged in selling supplemental health and life insurance through its subsidiaries: Aflac U.S. and Aflac Japan. Aflac Japan is the dominant segment, accounting for 75% of total revenues and 80% of total assets in 2004. The company markets individually underwritten policies, primarily through independent agents at worksites.
Key Financial Metrics
| Metric (in millions) | 2004 | 2003 |
|---|---|---|
| Total Revenues | $13,281 | $11,447 |
| Premiums Earned | $11,302 | $9,921 |
| Net Investment Income | $1,957 | $1,787 |
| Net Earnings | $1,299 | $795 |
| Diluted EPS | $2.52 | $1.52 |
| Total Assets | $59,326 | $50,964 |
| Shareholders' Equity | $7,573 | $6,646 |
| Notes Payable | $1,429 | $1,409 |
| Cash Flow from Operations | $4,486 | $3,389 |
Margins: The combined effective income tax rate was 28.1% in 2004 (down from 35.1% in 2003) due to a one-time tax benefit. Pretax operating earnings margins for Aflac Japan were 14.1% and for Aflac U.S. were 15.0%.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 16% to $13.3 billion, driven by a 14% increase in earned premiums. Aflac Japan premiums grew 14.2% (in dollars), while Aflac U.S. premiums grew 13.1%.
- Earnings Surge: Net earnings increased 63% to $1.3 billion. This growth was significantly aided by a $128 million non-recurring tax benefit from the release of a valuation allowance on deferred tax assets following the passage of the American Jobs Creation Act of 2004.
- Foreign Currency Impact: The yen strengthened against the dollar (year-end rate 104.21 vs. 107.13 in 2003). This translation effect increased reported net earnings by $39 million and total assets by $1.2 billion.
- Investment Results: Realized investment losses were minimal at $12 million in 2004, a significant improvement over the $301 million loss in 2003 (which included a major loss on Parmalat securities).
Guidance, Outlook, and Risks
- 2005 Guidance: Management projects net earnings per diluted share of at least $2.56 for 2005, representing a 14.8% increase over 2004. This projection assumes no impact from foreign currency translation, no realized investment gains/losses, and no non-recurring items.
- Sales Objectives: Aflac Japan aims for 5-10% growth in new annualized premium sales (in yen). Aflac U.S. targets 3-8% growth in new sales.
- Key Risks:
- Foreign Currency: Fluctuations in the yen/dollar exchange rate significantly impact reported results. A weaker yen suppresses reported growth.
- Investment Yields: Persistently low investment yields in Japan and the U.S. compress the spread between investment income and required interest on policy reserves.
- Regulatory: Operations are subject to strict solvency and dividend restrictions in both the U.S. (NAIC risk-based capital) and Japan (FSA solvency margins).
- Competition: Increased competition in Japan following market deregulation, though Aflac maintains a leading market position.
- Unusual Items: The 2004 results included a $3 million gain from the transfer of a Japanese pension obligation to the government. The 2003 results were negatively impacted by a $26 million charge for the Japanese policyholder protection fund.
Investor Verification Checklist
- Tax Benefit Sustainability: Verify the impact of the $128 million one-time tax benefit on the reported 63% earnings growth; core operating earnings growth was lower.
- Yen Sensitivity: Assess the sensitivity of future earnings to yen/dollar exchange rate fluctuations, as Aflac Japan comprises the majority of assets and revenue.
- Investment Spread: Monitor the narrowing spread between investment yields and the interest rate credited to policy reserves, particularly in the Japanese market.
- U.S. Sales Momentum: Review the recovery of U.S. sales growth following management changes in 2003/2004, as 2004 growth (5.1%) missed the 10-12% target.
- Reinsurance Exposure: Confirm the company's reinsurance strategy and exposure to large-scale claims, though the filing indicates minimal reinsurance ceded.